Skip to content

A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens

A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02518490
Enrollment
18
Registered
2015-08-07
Start date
2015-08-31
Completion date
2015-10-31
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

This was be a randomized, contralateral, double-masked, dispensing study comparing the Study test lens against the control lens over one month of lens wear. The study results were not used for design validation of test lens.

Detailed description

Subjects were randomized to wear the test lens in one eye and control lens in the other eye. Both test and control lenses were used in a daily wear modality for one month. The study results were not used for design validation of test lens.

Interventions

Each subject will be randomized to wear the test lens on one eye and control lens on one eye.

Each subject will be randomized to wear the test lens on one eye and control lens on one eye.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects will only be eligible for the study if: 1. Is at least 18 years of age for the USA and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. Is an adapted soft contact lens wearer; 5. Requires spectacle lens powers between -0.50 to -6.50 diopters sphere; 6. Has no more than 0.75 diopters of refractive astigmatism; 7. Willing to wear contact lens in both eyes; 8. Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye; 9. To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit as acceptable.

Exclusion criteria

* Subjects will not be eligible to take part in the study if: 1. Is participating in any concurrent clinical or research study; 2. Has any known active\* ocular disease and/or infection; 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study; 6. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit); 7. Is aphakic; 8. Has undergone refractive error surgery; \* For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Ratings for Comfort After Lens InsertionBaseline (5 minutes post lens dispensing)Subjective ratings for comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever
Percentage of Participants With a Lens Preference Based on Subjective ComfortBaseline (5 minutes post lens dispensing)Percentage of Participants with a Lens Preference Based on Subjective Comfort. Preferred Sapphire, Preferred Enfilcon A, No preference
Lens WettabilityBaseline (5 minutes post lens dispensing)Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)
Lens Surface DepositionBaseline (5 minutes post lens dispensing)Lens Surface Deposit was assessed on a scale of 0-4 (0-4, 0.25 steps)(0- Clean , no deposits, 1- 5 or less small deposits (\<0.1mm), 2- \>5 deposits of \<0.1mm size or film covering 25-50% of surface, 3 - Deposits of between 0.1 and 0.5amm or film covering 50-75% of surface, 4- Deposits of 0.5mm or larger or film covering more than 75% of surface)

Countries

United States

Participant flow

Participants by arm

ArmCount
Overall Study
Subjects were randomized to wear test lens in one eye and control lens in other eye for a one month period.
17
Total17

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
17 Participants
Age, Continuous29 years
STANDARD_DEVIATION 12
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
17 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 18
other
Total, other adverse events
0 / 180 / 18
serious
Total, serious adverse events
0 / 180 / 18

Outcome results

Primary

Lens Surface Deposition

Lens Surface Deposit was assessed on a scale of 0-4 (0-4, 0.25 steps)(0- Clean , no deposits, 1- 5 or less small deposits (\<0.1mm), 2- \>5 deposits of \<0.1mm size or film covering 25-50% of surface, 3 - Deposits of between 0.1 and 0.5amm or film covering 50-75% of surface, 4- Deposits of 0.5mm or larger or film covering more than 75% of surface)

Time frame: Baseline (5 minutes post lens dispensing)

ArmMeasureValue (MEAN)Dispersion
Sapphire LensesLens Surface Deposition0.06 units on a scaleStandard Deviation 0.17
Enfilcon ALens Surface Deposition0.03 units on a scaleStandard Deviation 0.12
Primary

Lens Surface Deposition

Lens Surface Deposit was assessed on a scale of 0-4 (0-4, 0.25 steps)(0- Clean , no deposits, 1- 5 or less small deposits (\<0.1mm), 2- \>5 deposits of \<0.1mm size or film covering 25-50% of surface, 3 - Deposits of between 0.1 and 0.5amm or film covering 50-75% of surface, 4- Deposits of 0.5mm or larger or film covering more than 75% of surface)

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensesLens Surface Deposition0.21 units on a scaleStandard Deviation 0.5
Enfilcon ALens Surface Deposition0.10 units on a scaleStandard Deviation 0.27
Primary

Lens Wettability

Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)

Time frame: Baseline (5 minutes post lens dispensing)

ArmMeasureValue (MEAN)Dispersion
Sapphire LensesLens Wettability3.4 units on a scaleStandard Deviation 0.4
Enfilcon ALens Wettability3.4 units on a scaleStandard Deviation 0.3
Primary

Lens Wettability

Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensesLens Wettability3.5 units on a scaleStandard Deviation 0.4
Enfilcon ALens Wettability3.6 units on a scaleStandard Deviation 0.3
Primary

Percentage of Participants With a Lens Preference Based on Subjective Comfort

Percentage of Participants with a Lens Preference Based on Subjective Comfort. Preferred Sapphire, Preferred Enfilcon A, No preference

Time frame: Baseline (5 minutes post lens dispensing)

ArmMeasureGroupValue (NUMBER)
Sapphire LensesPercentage of Participants With a Lens Preference Based on Subjective ComfortSapphire20 percentage of participants
Sapphire LensesPercentage of Participants With a Lens Preference Based on Subjective ComfortNo preference30 percentage of participants
Sapphire LensesPercentage of Participants With a Lens Preference Based on Subjective Comfortenfilcon A50 percentage of participants
Primary

Percentage of Participants With a Lens Preference Based on Subjective Comfort

Percentage of Participants with a Lens Preference Based on Subjective Comfort. Preferred Sapphire, Preferred Enfilcon A, No preference

Time frame: 4 weeks

ArmMeasureGroupValue (NUMBER)
Sapphire LensesPercentage of Participants With a Lens Preference Based on Subjective ComfortSapphire10 percentage of participants
Sapphire LensesPercentage of Participants With a Lens Preference Based on Subjective ComfortNo preference65 percentage of participants
Sapphire LensesPercentage of Participants With a Lens Preference Based on Subjective Comfortenfilcon A25 percentage of participants
Primary

Subjective Ratings for Comfort After Lens Insertion

Subjective ratings for comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever

Time frame: Baseline (5 minutes post lens dispensing)

ArmMeasureValue (MEAN)Dispersion
Sapphire LensesSubjective Ratings for Comfort After Lens Insertion91 units on a scaleStandard Deviation 11
Enfilcon ASubjective Ratings for Comfort After Lens Insertion93 units on a scaleStandard Deviation 12
Primary

Subjective Ratings for Comfort After Lens Insertion

Subjective ratings for comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensesSubjective Ratings for Comfort After Lens Insertion88 units on a scaleStandard Deviation 11
Enfilcon ASubjective Ratings for Comfort After Lens Insertion87 units on a scaleStandard Deviation 15

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026